Home » Topics » BioWorld Science

BioWorld Science
RSS

Luye initiates phase III trials in China with LY-01005 for prostate cancer

Sep. 7, 2018

Eli Lilly presents AOC3 inhibitors

Sep. 7, 2018

Phase IIa study of Yeliva for cholangiocarcinoma advances to second stage

Sep. 7, 2018

FDA approves Tiglutik oral suspension for the treatment of ALS

Sep. 7, 2018

Chinese researchers disclose Abeta aggregation inhibitors

Sep. 7, 2018

Xenon Pharmaceuticals to develop ezogabine for KCNQ2 epileptic encephalopathy

Sep. 7, 2018

A*STAR identifies new SMYD3 inhibitors for cancer

Sep. 7, 2018

Torrent Pharmaceuticals patents compounds for asthma and COPD

Sep. 7, 2018

Researchers identify FHOD3 as a novel disease-causing gene in hypertrophic cardiomyopathy

Sep. 7, 2018

Combining ACE2 and BNP biomarkers improves risk stratification in patients with aortic stenosis

Sep. 7, 2018

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...